Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Propofol and thiopental are two intravenous anesthetic agents that can be used in combination or as alternatives to each other. Propofol (2,6-diisopropylphenol) is a rapid-onset, short-acting intravenous anesthetic used for induction and maintenance of general anesthesia. Thiopental (also known as thiopental sodium or thiopentone) is a short-acting barbiturate used for anesthesia induction. When used together, they have been found to have synergistic hypnotic effects. The combination may be used in specific clinical scenarios, though they are more commonly used as alternatives to each other rather than in combination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propofol + thiopental.